Sintx Technologies (SINT) Restructuring Costs (2024)
Sintx Technologies (SINT) recorded quarterly Restructuring Costs of $145000.0 in Q4 2024, down 96.75% quarter-over-quarter from $4.5 million in Q3 2024.
Sintx Technologies (SINT) Restructuring Costs (2024) Analysis & Trends
Sintx Technologies' Restructuring Costs history runs 1 years deep, the most recent figure standing at $145000.0 for Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.79 Mn | 6.90 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 145,000.00 |
| Sep 30, 2024 | 4.46 Mn |